Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Xcyte Digital Corp. Releases "Xperience" Subscription Service (click to learn more) Star Diamond: High Modelled Diamond Prices and High Proportions of Type IIa Diamonds (click to learn more) Northstar Discovers Large Near Surface EM Conductor SE of Cam Copper Mine (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News BioRestorative Therapies Inc BRTX

Healthcare Biotechnology
BioRestorative Therapies, Inc. is engaged in developing therapeutic products and medical therapies using cell and tissue protocols, primarily involving adult stem cells. The Company has two core programs that relate to the treatment of disc/spine disease and metabolic disorders. Its lead cell therapy candidate, BRTX-100, is a product formulated from autologous (or a person's own) cultured... see more

Recent & Breaking News (NDAQ:BRTX)

BioRestorative Therapies' Brown Fat Stem Cells Research Published in February Issue of Stem Cells Journal

Business Wire January 14, 2014

BioRestorative Therapies' ThermoStem® Brown Fat Stem Cell Study to be Published in Stem Cells

Business Wire December 2, 2013

BioRestorative Therapies to Present at LD Micro Conference

Business Wire November 25, 2013

BioRestorative Engages Consulting Firm to Advance brtxDISC(TM) Program Delivery Device through FDA Clearance Process

Business Wire September 30, 2013

BioRestorative Therapies Receives Approval to Conduct Retrospective Safety Study on its Bulging/Herniated Disc Procedure

PR Newswire August 6, 2013

BioRestorative Therapies Provides Company Updates with Shareholder Letter

PR Newswire August 1, 2013

BioRestorative Therapies CEO Mark Weinreb Interviewed by The Life Sciences Report

Marketwired July 25, 2013

BioRestorative Therapies Expands its ThermoStem® Program to 150 Stem Cell Lines

PR Newswire June 24, 2013

BioRestorative Therapies CEO Mark Weinreb Interviewed on "Next Big Thing" with Financial Personality and Founder Tobin Smith

PR Newswire June 17, 2013

BioRestorative Therapies Announces the Development of an Extract that has Promise for Use in Beauty Care Products

PR Newswire May 29, 2013

BioRestorative Therapies, Inc. to Present at the Marcum MicroCap Conference

PR Newswire May 21, 2013

BioRestorative Therapies, Inc. to Present at the Marcum MicroCap Conference

PR Newswire May 21, 2013

BioRestorative Therapies Signs Agreement with Dexterity, Inc. to Advance Production of the Company's Novel brtxDISC(TM) Stem Cell Therapy Device

PR Newswire May 20, 2013

BioRestorative Therapies Announces One-for-Fifty Reverse Stock Split

PR Newswire April 12, 2013

BioRestorative Therapies Announces Chairman of Its Scientific Advisory Board to Speak at Vatican

PR Newswire April 9, 2013

BioRestorative Therapies Announces Participation in Adipose Tissue Biology Keystone Conference Series

PR Newswire January 14, 2013